This is a snippet of the transcript, sign up to read more.
What happened was we had a department that was growing significantly. We started receiving demand from hospitals that didn't need an EHR. So, we decided to try selling revenue cycle services independently of the EHR. I assigned a couple of salespeople to this task, and they had some success. However, most times we approached a hospital to sell the revenue cycle services standalone, the information systems staff thought we were trying to sell them an EHR because we were CPSI. This created confusion within the hospital and the market. People wondered what CPSI was doing. At the time, outsourcing the management of information services departments was becoming big business. Companies like McKesson, Siemens, and TDS, as well as HBOC before McKesson acquired them, provided outsourcing services to manage information systems departments, which were significant revenue streams. They used this as a Trojan horse to get their systems into hospitals.Once you're in, you cross-sell. That's why hospitals feared we would try to sell our revenue cycle systems. They were content with Meditech, Cerner, or any provider that wasn't CPSI. After responding to enough inquiries, we decided to rebrand our revenue cycle services. In 2013, we created TruBridge, which emerged from an existing business division. It included revenue cycle, electronic billing, patient accounting functions, and contract management. We bundled these services together and named it TruBridge. Then, we needed a name for the EHR business. In 2014, we came up with Evident. We couldn't call the system the CPSI system anymore, so we named the EHR Thrive. That's how Thrive came about.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2025 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research